Lepik K, Mikhailova N, Kondakova E, et al. Nivolumab for treatment of patients with relapsed/refractory classical Hodgkin’s lymphoma (CHL): clinical and patient-reported outcomes. 24th Congress of EHA, abstract PS1239.
Slechtere prognose bij ALL door downsyndroom en IKZF1-deletie
jan 2022 | Leukemie